(Press-News.org) (Vancouver – February 20, 2013) – Doctors should not be discouraged from prescribing isotretinoin to adolescents for inflammatory acne, according to a new study by Canadian and U.S. scientists showing the drug does not increase the risk of inflammatory bowel disease (IBD).
Led by Dr. Mahyar Etminan of the Child & Family Research Institute at BC Children's Hospital, the Provincial Health Services Authority and the University of British Columbia, the scientists addressed this important drug safety question because of a previous study linking the drug to IBD. In this new report published February 20, 2013 in the medical journal JAMA Dermatology, Dr. Etminan's team says theirs is the first to statistically adjust for severe acne, which is a strong confounding variable that may have led to the overestimation of risk in the earlier study.
The JAMA Dermatology report covered two studies. In one study, the researchers analyzed the health records of a large population of U.S. women between 24-34 years of age. Of the women, 2159 had IBD and 43,180 did not. Only 10 (0.46 per cent) of the women with IBD and only 191 (0.44 per cent) of the women who did not have IBD had used isotretinoin. In the second study, the researchers comprehensively reviewed and analyzed the results of published and unpublished studies. They did not find that isotretinoin increases the risk of IBD.
"We've come to the conclusion that there's no risk that the drug causes inflammatory bowel disease," says Dr. Etminan. "This drug is used for very severe acne that is very traumatic with psychological effects, and it is very effective. Hopefully with this study, it may put dermatologists at ease with prescribing this drug to children and adolescents, knowing that it doesn't cause this adverse effect."
###
This research was unfunded. Dr. Etminan is a scientist with the Therapeutic Evaluation Unit at the Child & Family Research Institute and the Provincial Health Services Authority. He is appointed in the Faculty of Medicine at the University of British Columbia. The study was co-led by Dr. James Brophy of McGill University.
The Child & Family Research Institute conducts discovery, translational and clinical research to benefit the health of children and their families. CFRI is supported by BC Children's Hospital Foundation and works in close partnership with the University of British Columbia,
BC Children's Hospital, and BC Women's Hospital & Health Centre (agencies of the Provincial Health Services Authority). For more information, visit www.cfri.ca.
BC Children's Hospital, an agency of the Provincial Health Services Authority, is British Columbia's (B.C.'s) only pediatric hospital and home to many specialized pediatric services available nowhere else in the province, including B.C.'s trauma centre for children, pediatric intensive care, kidney and bone marrow transplants, open heart surgery, neurosurgery and cancer treatment. Sunny Hill Health Centre for Children is the provincial facility that offers specialized child development and rehabilitation services to children and youth. For more information, please visit www.bcchildrens.ca.
The Provincial Health Services Authority (PHSA) plans, manages and evaluates selected specialty and province-wide health care services across BC, working with the five geographic health authorities to deliver province-wide solutions that improve the health of British Columbians. For more information, visit www.phsa.ca.
The University of British Columbia (UBC) is one of North America's largest public research and teaching institutions, and one of only two Canadian institutions consistently ranked among the world's 22 best universities. Surrounded by the beauty of the Canadian West, it is a place that inspires bold, new ways of thinking that have helped make it a national leader in areas as diverse as community service learning, sustainability and research commercialization. UBC offers more than 56,000 students a range of innovative programs and attracts $550 million per year in research funding from government, non-profit organizations and industry through over 8,000 projects and grants. For more information, please visit www.ubc.ca.
Contact:
Jennifer Kohm, Child & Family Research Institute
T: 604-875-2401 // jkohm@cfri.ca END
Common acne drug not associated with increased risk of IBD
2013-02-21
ELSE PRESS RELEASES FROM THIS DATE:
New bioengineered ears look and act like the real thing
2013-02-21
NEW YORK (Feb. 20, 2013) -- Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.
In their PLOS ONE study, the researchers demonstrate how 3D printing and new injectable gels made of living cells can be used to fashion ears ...
UCLA life scientists identify drug that could aid treatment of anxiety disorders
2013-02-21
The drug scopolamine has been used to treat a variety of conditions, including nausea and motion sickness. A new study by UCLA life scientists suggests that it may also be useful in treating anxiety disorders.
Researchers found that the drug can help boost the effectiveness of a common treatment for anxiety disorders known as exposure therapy. In exposure therapy, a subject with a phobia or anxiety is repeatedly exposed to the object or situation they fear, in a non-threatening setting. The goal of this treatment is to ultimately lessen and eliminate the fear — in essence, ...
Explosives vapor detection technology: The new 'sniff test'
2013-02-21
RICHLAND, Wash. – A quick, accurate and highly sensitive process to reliably detect minute traces of explosives on luggage, cargo or travelling passengers has been demonstrated by scientists at the Department of Energy's Pacific Northwest National Laboratory. The vapor detection technology accurately detects and identifies the vapors of even very low-volatility explosives in real time at ambient temperature and without sample pre-concentration. Details are outlined in a recent issue of Analytical Chemistry.
Rather than searching for particle residue using a typical method ...
Science synthesis to help guide land management of nation's forests
2013-02-21
ALBANY, Calif.—A team of more than a dozen scientists from the U.S. Forest Service's Pacific Southwest (PSW) and Pacific Northwest research stations, universities and Region 5 Ecology Program recently released a synthesis of relevant science that will help inform forest managers as they revise plans for the national forests in the Sierra Nevada and southern Cascades of California. The three most southern national forests in the Sierra Nevada—Inyo, Sequoia and Sierra—will be among the first of the 155 national forests to update their management plans. The new planning rule ...
Cooling may prevent trauma-induced epilepsy
2013-02-21
In the weeks, months and years after a severe head injury, patients often experience epileptic seizures that are difficult to control. A new study in rats suggests that gently cooling the brain after injury may prevent these seizures.
"Traumatic head injury is the leading cause of acquired epilepsy in young adults, and in many cases the seizures can't be controlled with medication," says senior author Matthew Smyth, MD, associate professor of neurological surgery and of pediatrics at Washington University School of Medicine in St. Louis. "If we can confirm cooling's effectiveness ...
The brainless origin of our head
2013-02-21
In many animals, the brain is located in a specific structure, the head, together with sensory organs and often together with the mouth. However, there are even more distantly related animals, which have a nervous system, but no brain, like sea anemones and corals.
In this collaborative study between a research group led by Fabian Rentzsch (Sars Centre Bergen) and Ulrich Technau from the Dept. of Molecular Evolution and Development the sea anemone Nematostella vectensis was used to find out if one of the ends of the sea anemone corresponds to the head of higher animals. ...
Aspirin and omega-3 fatty acids work together to fight inflammation
2013-02-21
Experts tout the health benefits of low-dose aspirin and omega-3 fatty acids found in foods like flax seeds and salmon, but the detailed mechanisms involved in their effects are not fully known. Now researchers reporting in the February 21 issue of the Cell Press journal Chemistry & Biology show that aspirin helps trigger the production of molecules called resolvins that are naturally made by the body from omega-3 fatty acids. These resolvins shut off, or "resolve," the inflammation that underlies destructive conditions such as inflammatory lung disease, heart disease, ...
Why living against the clock is a risky business
2013-02-21
Living against the clock—working late-night shifts or eating at inappropriate times, for example—can come with real health risks, metabolic syndrome, obesity, and diabetes among them. Now, researchers reporting in Current Biology, a Cell Press publication, on February 21 have new evidence to explain why it matters not just what mice (or by extension, people) eat, but also when they eat it.
Insulin action rises and falls according to a 24-hour, circadian rhythm, the researchers found. What's more, mice unable to keep the time for one reason or another get stuck in an insulin-resistant ...
For monarchs to fly north, first they've got to chill
2013-02-21
Monarch butterflies are well known for their ability to fly 2,000 miles south from North America to Mexico each fall and back again in the spring. Now, researchers reporting in Current Biology, a Cell Press publication, on February 21 have evidence to show that the butterflies would just keep on heading south if it weren't for the chilly weather.
The findings help to explain why the butterflies spend the winter on frosty mountaintops. They also imply that global climate change could profoundly influence the monarchs' migrations, the researchers say.
"The monarchs need ...
Biomarker may identify neuroblastomas with sensitivity to BET bromodomain inhibitors
2013-02-21
PHILADELPHIA — Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors.
The researchers made this discovery in a preclinical study, which was funded in part by a Stand Up To Cancer Innovative Research Grant and was published in Cancer Discovery, a journal of the American Association for Cancer Research.
"BET ...